(Q35603932)

9 August 2017

1 reference

title

ADMA and oxidative stress (English)

1 reference

9 August 2017

Karsten Sydow

1

1 reference

PubMed ID

14664902

9 August 2017

Thomas Münzel

series ordinal

2

1 reference

9 August 2017

1 December 2003

1 reference

Atherosclerosis. Supplements

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

41-51

1 reference

9 August 2017

4

1 reference

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Does ADMA cause endothelial dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Antioxidants and atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

NAD(P)H oxidase: role in cardiovascular biology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Myeloperoxidase, a leukocyte-derived vascular NO oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Mechanism of superoxide generation by neuronal nitric-oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Mechanisms underlying endothelial dysfunction in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Isoforms of nitric oxide synthase Characterization and purification from different cell types

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Regulation of enzymes of the urea cycle and arginine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Nitric oxide synthases: properties and catalytic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Arginine metabolism: nitric oxide and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Functional and analytical evidence for scavenging of oxygen radicals by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Are ACE inhibitors a "magic bullet" against oxidative stress?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900033-3

7 January 2021

10.1016/S1567-5688(03)00033-3

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14664902